British Journal of Diabetes

Journal Information
ISSN / EISSN : 23976233 / 23976241
Current Publisher: ABCD Diabetes Care, Ltd. (10.15277)
Former Publisher: SAGE Publications (10.1177)
Total articles ≅ 1,052
Current Coverage
ESCI
Filter:

Latest articles in this journal

Alexander R Charlton, Jessica R Charlton
British Journal of Diabetes, Volume 19, pp 141-146; doi:10.15277/bjd.2019.224

The publisher has not yet granted permission to display this abstract.
Amanda Gleeson, Mark Davies, Brona Roberts, Ailsh Nugent
British Journal of Diabetes, Volume 19, pp 105-109; doi:10.15277/bjd.2019.225

The publisher has not yet granted permission to display this abstract.
Association of British Clinical Diabetologists
British Journal of Diabetes, Volume 19, pp 152-155; doi:10.15277/bjd.2019.234

Nitisha Khunti, Nehal Khunti, Kamlesh Khunti
British Journal of Diabetes, Volume 19, pp 99-104; doi:10.15277/bjd.2019.223

Abstract:Tight glycaemic control is essential, and good adherence is associated with a lower risk of all-cause mortality and hospitalisation in people with T2D. A significant number of people with T2D do not take medication as prescribed and therefore have poor outcomes. The key factors for not achieving targets include therapeutic inertia and adherence. Reasons for poor adherence include perception of treatment, complexity of treatment and adverse effects. Poor adherence leads to inadequate glycaemic control, which increases the risk of diabetic complications and mortality. There is evidence to suggest that education and monitoring is important in medication adherence.
Miles Fisher
British Journal of Diabetes, Volume 19, pp 133-135; doi:10.15277/bjd.2019.230

The publisher has not yet granted permission to display this abstract.
M Joan Taylor, Krishan P Chauhan, Tarsem S Sahota
British Journal of Diabetes, Volume 19, pp 124-130; doi:10.15277/bjd.2019.228

The publisher has not yet granted permission to display this abstract.
Tim Street, Thomas Sj Crabtree, Emma G Wilmot
British Journal of Diabetes, Volume 19, pp 136-140; doi:10.15277/bjd.2019.231

Dinesh Nagi, Umesh Dashora, Rebecca Reeve, Tim Robbins, Pratik Choudhury
British Journal of Diabetes, Volume 19, pp 156-161; doi:10.15277/bjd.2019.235

Caroline Day
British Journal of Diabetes, Volume 19, pp 147-149; doi:10.15277/bjd.2019.232

Robert Ej Ryder, Susan P Irwin, Wyn Burbridge, Hardeep Gandhi, Tahira Bashir, Rachael A Allden, Mordel Wilson, Melanie Wyres, Melissa Cull, Mahi Yadagiri, et al.
British Journal of Diabetes, Volume 19, pp 110-117; doi:10.15277/bjd.2019.226

Abstract:Aims: EndoBarrier is a 60 cm proximal intestinal liner, endoscopically implanted for up to 1 year, designed to mimic the bypass aspect of Roux-en-Y gastric bypass surgery. We aimed to assess its safety and efficacy in patients with advanced diabesity.Methods: Since October 2014 we have implanted 62 Endo-Barriers in our NHS service. By November 2018 all were explanted. Outcomes were monitored in a registry.Results: In 61 of the 62 patients (98.4%) (age 51.4±7.2 years, 54.1% male, 57.4% Europid, diabetes duration 12.0 (8.0–19.5) years, 57.4% insulin-treated, BMI 41.9±7.4 kg/m2) with implant and explant data, mean±SD HbA1c fell by 23.7±21.4 mmol/mol from 80.2±22.5 to 56.5±11.5 mmol/mol (p